Short Communication
Microplastic-Induced Redox Imbalance and Its Role in Non-Enzymatic Glycation with Implications for Aging and Disease Pathogenesis
Mohammad Nadeem Khan*
Corresponding Author: Mohammad Nadeem Khan, Department of Pharmacology (Clinical Pharmacology), Sri Aurobindo Medical College & PG Institute, Indore, India.
Received: February 25, 2025; Revised: March 04, 2025; Accepted: March 07, 2025 Available Online: March 20, 2025
Citation: Khan MN. (2025) Microplastic-Induced Redox Imbalance and Its Role in Non-Enzymatic Glycation with Implications for Aging and Disease Pathogenesis. BioMed Res J, 9(1): 837-839.
Copyrights: ©2025 Khan MN. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share :
  • 98

    Views & Citations
  • 10

    Likes & Shares
Microplastics (MPs), defined as plastic particles less than 5 mm in size, have emerged as pervasive environmental contaminants with significant implications for human health. Beyond their well-documented ecological impact, MPs have been linked to oxidative stress, mitochondrial dysfunction, and metabolic disorders, contributing to the formation of Advanced Glycation End-products (AGEs) through non-enzymatic glycation (NEG). AGEs play a crucial role in aging and the pathogenesis of chronic diseases, including diabetes, neurodegenerative disorders, and cardiovascular dysfunction. This short communication consolidates current knowledge on the molecular mechanisms underlying MP-induced redox imbalance, mitochondrial dysfunction, and AGE accumulation. MPs generate excessive reactive oxygen species (ROS), disrupt mitochondrial homeostasis, and facilitate glycoxidation, thereby exacerbating metabolic dysregulation. Additionally, MP-associated AGEs interact with receptors such as RAGEs, triggering chronic inflammation and accelerating age-related pathologies. Understanding the interplay between MPs, oxidative stress, and NEG provides critical insights into their systemic toxicity and long-term health effects. This also identifies potential biomarkers, therapeutic interventions, and regulatory strategies to mitigate MP-associated metabolic disturbances, highlighting future research directions in environmental toxicology and metabolic disease prevention.

Keywords: Microplastics, Oxidative stress, Mitochondrial dysfunction, Non-enzymatic glycation, Advanced glycation end-products, Metabolic disorders, Aging, Environmental toxicology
INTRODUCTION

Microplastics (MPs), defined as plastic particles less than 5 mm in size, have become a significant environmental contaminant with increasing evidence of their impact on human health. Initially studied for their ecological effects, MPs are now recognized as a major contributor to oxidative stress, mitochondrial dysfunction, and metabolic disorders [1]. Their persistent presence in food, water, and air raises concerns about long-term systemic toxicity, particularly through the induction of redox imbalance and non-enzymatic glycation (NEG). NEG, a spontaneous reaction between reducing sugars and biomolecules, leads to the accumulation of Advanced Glycation End-products (AGEs), which contribute to aging and chronic diseases, including diabetes, neurodegenerative disorders, and cardiovascular conditions [2].

MP exposure generates excessive reactive oxygen species (ROS), surpassing the cellular antioxidant defense system, thereby creating a state of oxidative stress [3]. This redox imbalance disrupts mitochondrial function, triggering a vicious cycle of ROS overproduction, mitochondrial DNA (mtDNA) damage, and compromised bioenergetic efficiency [4]. Mitochondria, as central regulators of cellular metabolism, become primary sites of damage, contributing to inflammatory responses and metabolic dysregulation [5]. This short communication examines the mechanistic pathways linking MP-induced oxidative stress, mitochondrial dysfunction, and NEG, providing an integrative perspective on their role in disease progression.

MICROPLASTICS AND REDOX IMBALANCE: MOLECULAR BASIS

MPs induce oxidative stress through direct and indirect mechanisms. Direct effects include physicochemical interactions between MP particles and cellular membranes, leading to lipid peroxidation and protein carbonylation [6].

Indirectly, MPs act as carriers for heavy metals, persistent organic pollutants (POPs), and endocrine-disrupting chemicals (EDCs), all of which contribute to ROS generation and mitochondrial dysfunction [7]. The oxidative environment promotes glycoxidation, a process that accelerates AGE formation, further exacerbating metabolic dysfunction [8].

MP-associated AGEs interact with their receptors (RAGEs), initiating pro-inflammatory signaling cascades, activating nuclear factor kappa B (NF-κB), and upregulating cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) [9]. This chronic inflammatory state perpetuates cellular damage and accelerates age-related diseases, including insulin resistance and neurodegeneration [10].

MITOCHONDRIAL DYSFUNCTION AND AGE ACCUMULATION

Mitochondria play a dual role in MP-induced toxicity: they act as both a source and a target of oxidative stress. MP exposure disrupts mitochondrial membrane potential, leading to increased proton leakage, impaired ATP synthesis, and apoptosis [11]. The oxidative modifications of mitochondrial proteins and lipids contribute to defective mitophagy, further aggravating cellular stress [12]. Additionally, MP-induced mitochondrial dysfunction has been linked to impaired glucose metabolism and insulin signaling, reinforcing the association between MPs, NEG, and metabolic disorders [13].

IMPLICATIONS FOR AGING AND DISEASE PATHOGENESIS

The link between MP exposure and metabolic dysfunction highlights an urgent need for further research into its role in aging and chronic disease progression. Persistent MP exposure accelerates biological aging through oxidative stress-induced telomere attrition, DNA methylation alterations, and mitochondrial biogenesis impairment [14]. Additionally, the role of AGEs in neurodegenerative diseases, such as Alzheimer's and Parkinson's, underscores the relevance of MP-mediated glycation in neuronal aging [15]. Cardiovascular diseases, another significant aging-related pathology, are exacerbated by MP-induced endothelial dysfunction and inflammation, reinforcing their contribution to systemic metabolic imbalance [16].

FUTURE DIRECTIONS AND SCOPE

This short communication aims to consolidate existing evidence on the molecular mechanisms underlying MP-induced oxidative stress, mitochondrial dysfunction, and AGE accumulation. By integrating findings from environmental toxicology, molecular biology, and metabolic research, we seek to establish a comprehensive framework for understanding MP-associated disease risk. Future research should focus on:

  1. Identifying biomarkers for MP-induced oxidative damage and glycation pathways [17].
  2. Developing therapeutic strategies to mitigate MP-induced metabolic stress, including antioxidant supplementation and autophagy modulation [18].
  3. Investigating potential interventions, such as dietary modifications and regulatory policies, to limit MP exposure and its systemic effects [19].

CONCLUSION

Microplastics are increasingly implicated in oxidative stress-mediated metabolic disruptions, highlighting their significant impact on human health. This short communication elucidates the molecular basis of MP-induced redox imbalance, mitochondrial dysfunction, and AGE accumulation, establishing a mechanistic link between environmental microplastic exposure and metabolic disease pathogenesis. The excessive ROS production associated with MPs disrupts mitochondrial integrity, exacerbates glycoxidation, and amplifies chronic inflammation, collectively accelerating aging-related diseases. Given the growing evidence of MPs’ systemic toxicity, future research should prioritize the identification of reliable biomarkers for MP-induced oxidative damage, the development of therapeutic strategies to mitigate metabolic stress, and policy-driven interventions to reduce human exposure. By addressing these critical knowledge gaps, this short communication contributes to a deeper understanding of MP toxicity and underscores the need for proactive public health measures to combat its biochemical and physiological consequences.

ACKNOWLEDGMENTS

The author would like to express sincere gratitude to Sri Aurobindo Medical College and PG Institute, SAIMS Hospitals, Sanwer Road, Indore, Madhya Pradesh, India, 45355, and Sri Aurobindo University (SAU), Indore, India. The support, facilities, and resources provided by both institutions were instrumental in the successful completion of this research.

 

  1. Wright SL, Kelly FJ (2017) Plastic and human health: A micro issue? Environ Sci Technol 51(12): 6634-6647.
  2. Prata JC, Silva ALP, Walker TR, Duarte AC, Rocha-Santos T (2020) Environmental exposure to microplastics: An overview on possible human health effects. Sci Total Environ 702: 134455.
  3. Yee MS, Hii LW, Looi CK, Lim WM, Wong SF, et al. (2021) Impact of microplastics and nanoplastics on human health. Nanomaterials (Basel) 11(2): 496.
  4. Rahman A, Sarkar A, Yadav OP, Achari G, Slobodian P, et al. (2021) Potential human health risks due to environmental exposure to nano-and microplastics and knowledge gaps: A scoping review. Sci Total Environ 757: 143872.
  5. Vethaak AD, Legler J (2021) Microplastics and human health. Science 371(6530): 672-674.
  6. Ibrahim YS, Anuar TS, Azmi AA, Wan Mohd Khalik WMA, Lehata S, et al. (2021) Detection of microplastics in human colectomy specimens. JGH Open 5(10): 116-121.
  7. Jin Y, Xia J, Pan Z, Yang J, Wang W, et al. (2018) Polystyrene microplastics induce microbiota dysbiosis and inflammation in the gut of adult zebrafish. Environ Pollut 235: 322-329.
  8. Amato-Lourenço LF, Carvalho-Oliveira R, Ribeiro Jr G, Galvão LDS, Ando RA, et al. (2021) Presence of airborne microplastics in human lung tissue. J Hazard Mater 416: 126124.
  9. Lim X (2021) Microplastics are everywhere but are they harmful? Nature 593(7857): 22-25.
  10. Smith M, Love DC, Rochman CM, Neff RA (2018) Microplastics in seafood and the implications for human health. Curr Environ Health Rep 5(3): 375-86.
  11. Wang J, Tan Z, Peng J, Qiu Q, Li M (2016) The behaviors of microplastics in the marine environment. Mar Environ Res 113: 7-17.
  12. Rodrigues JP, Duarte AC, Santos-Echeandia J, Rocha-Santos T (2019) Significance of interactions between microplastics and POPs in the marine environment. Trends Anal Chem 111: 252-260.
  13. de Souza Machado AA, Kloas W, Zarfl C, Hempel S, Rillig MC (2018) Microplastics as an emerging threat to terrestrial ecosystems. Glob Change Biol 24(4): 1405-1416.
  14. Revel M, Châtel A, Mouneyrac C (2018) Micro(nano)plastics: A threat to human health? Curr Opin Environ Sci Health 1: 17-23.
  15. Yang Y, Liu W, Zhang Z, Grossart HP, Gadd GM (2020) Microplastics provide new microbial niches in aquatic environments. Appl Microbiol Biotechnol 104(15): 6501-6511.